Telix PharmaceuticalsTLX -1.93%50 Days Inventory is 33.73 as of Dec. 2025, which is 7% below its 10-year median of 36.09. GuruFocus rates TLX with a GF Score™ of 50/100 and a GF Value™ of $29.73 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 639 Biotechnology companies, Telix Pharmaceuticals ranks better than 91.39% on this metric.
The historical rank and industry rank for Telix Pharmaceuticals's Days Inventory or its related term are showing as below:
TLX'
s Days Inventory Range Over the Past 10 Years
Min: 27.29 Med: 36.09 Max: 293.19
Current: 31.23
During the past 11 years, Telix Pharmaceuticals's highest Days Inventory was 293.19. The lowest was 27.29. And the median was 36.09.
TLX's Days Inventory is ranked better than 91.39% of 639
companies
in the Biotechnology industry
Industry Median: 183.97
vs TLX: 31.23
Telix Pharmaceuticals's Days Inventory
declined
from Dec. 2024 (41.18) to Dec. 2025 (33.73).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Telix Pharmaceuticals's Inventory Turnover for the
six
months ended in Dec. 2025 was 5.41.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Telix Pharmaceuticals's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.09.
Telix Pharmaceuticals (NAS:TLX) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Telix Pharmaceuticals's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Telix Pharmaceuticals's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Telix Pharmaceuticals Days Inventory Related Terms
Telix Pharmaceuticals Days Inventory Historical Data
* Premium members only.
The historical data trend for Telix Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TLX vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Telix Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Telix Pharmaceuticals Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Telix Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Telix Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Telix Pharmaceuticals (TLX) has a Days Inventory of 33.73 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Telix Pharmaceuticals and its competitors. This is near median its historical median of 36.09. Over the past decade, Telix Pharmaceuticals' Days Inventory has ranged from 27.29 to 293.19. According to the industry distribution chart, Telix Pharmaceuticals ranks #55 out of 639 companies in the Biotechnology industry, placing it in the top 8.6%.
Is Telix Pharmaceuticals' Days Inventory too high?
Telix Pharmaceuticals' current Days Inventory of 33.73 is near median its 10-year median of 36.09. Over the past 10 years, this metric has ranged from a low of 27.29 to a high of 293.19. The Biotechnology industry median Days Inventory is 183.97. Telix Pharmaceuticals' value of 33.73 is 81.7% below this industry median. Based on the distribution chart, Telix Pharmaceuticals ranks #55 out of 639 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Telix Pharmaceuticals has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Telix Pharmaceuticals' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Telix Pharmaceuticals ranks #55 out of 639 companies for Days Inventory. This places Telix Pharmaceuticals in the top 9% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.97. Telix Pharmaceuticals' value of 33.73 is 81.7% below this benchmark. Historically, Telix Pharmaceuticals' own Days Inventory has ranged from 27.29 to 293.19 over the past decade. While the company's 10-year median is 36.09 vs. the industry median of 183.97, Telix Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.97, based on 639 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Telix Pharmaceuticals's current Days Inventory of 33.73 is 81.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Telix Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Inventory is 183.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Telix Pharmaceuticals's current Days Inventory is 33.73, which is near median its own 10-year median of 36.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telix Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Telix Pharmaceuticals (TLX) is currently considered Possible Value Trap. The stock's GF Value™ is $29.73, compared to a current price of $10.67 — trading 64.1% below its estimated fair value. The current Days Inventory is 33.73, which is near median its 10-year median of 36.09 and 81.7% below the Biotechnology industry median of 183.97. Telix Pharmaceuticals' overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Telix Pharmaceuticals (TLX), the current Days Inventory is 33.73 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Telix Pharmaceuticals (TLX) Overvalued in 2026?
Based on GuruFocus' analysis, Telix Pharmaceuticals stock appears to be undervalued.
The current stock price of $10.67 is trading 64.1% below its estimated GF Value™ of $29.73.
GuruFocus considers Telix Pharmaceuticals to be Possible Value Trap.
Key valuation signals for TLX:
Days Inventory: 33.73 (near median its 10-year median of 36.09)
GF Value™: $29.73 vs. price of $10.67 (64.1% below fair value)
Industry Position: 81.7% below the Biotechnology median (#55 of 639)
No single metric tells the full story. See the TLX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
50GF Score
Get the complete analysis for TLX
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TLX has been successfully added to your 
